Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from NBIX

Vertex Among 9 Stocks To Watch In Struggling Market

As the market indexes work through a downturn, Vertex is among nine stocks to watch showing relative strength.

Investors Business Daily

The Market Slumped Last Week; Why IBD Stock Of The Day Neurocrine Biosciences Didn't

Neurocrine Biosciences is the IBD Stock Of The Day as market uncertainty shakes plenty leading of equities — but not NBIX stock.

Investors Business Daily

S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market

S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Rise: Fed Rate Hike Looms, But This Is What Matters; Tesla Flirts With Buy Points

At least the stock market isn't rallying into the Fed meeting. Expect another 75-basis-point rate hike, with more to come. Tesla stock flirted with buy points.

Investors Business Daily

S&P 500 Dividend Standout Leads 5 Resilient Stocks Near Buy Points As Fed Looms

S&P 500 dividend standout Devon Energy leads this weekend's watch list of stocks near buy points in a tough market.

Investors Business Daily

Dow Jones Futures Fall, FedEx Dives; Stock Market Set To Break Key Level As Bull Case Turns Bearish

Dow Jones futures: The stock market is still reeling from the Fed bull case turning into bigger rate hikes for longer. FedEx dived on earnings.

Investors Business Daily

Dow Jones Futures: Why The Market Rally Is Stronger Than It Looks; Tesla Leads 5 Stocks In Buy Areas

The stock market rally is reviving, but is even stronger than the major indexes suggest. Tesla is among stocks in buy areas.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Neurocrine Leads 5 Stocks To Watch In Sickly Market

Neurocrine Biosciences leads five medical stocks near key support levels as the health care sector shows resilience in a sickly market.

Investors Business Daily

Dow Jones Futures Rise; Energy Prices Lower Despite Surprise OPEC+ Move, Russia News

Futures rose modestly. Oil prices erased gains despite OPEC+ cut production while natgas fell despite Russia cutting off European natural gas.

Investors Business Daily

Dow Jones Futures Fall: China Export Curbs On Nvidia, AMD Hit Chip Stocks

Futures fell as China export restrictions on Nvidia, AMD hit chip stocks. China EV sales were mixed.

Investors Business Daily

How IBD Stock Of The Day Neurocrine Bio Shrugged Off A High-Profile Failure

Neurocrine is shrugging off market woes, buoyed by movement drug Ingrezza and NBIX stock investors' hope for its pipeline.

Investors Business Daily

Dow Jones Futures: Jobs Report Tests 'Soft Landing' Market Rally; Tesla Stock Split Approved

The indexes were quiet before the July jobs report tests the Fed's soft landing. Tesla shareholders OK'd a 3-for-1 stock split.

Investors Business Daily

Neurocrine Shelves A Closely Watched Drug, But Stock Upbeat On Quarterly Win

Neurocrine Biosciences said Thursday its essential tremor study didn't pan out, and it shuttered the program. But NBIX stock jumped Friday.

Investors Business Daily

Dow Jones Futures: Snap Crash Hits Online Giants After Tesla Drives Market Rally Higher

Tesla led the market rally Thursday, with a few more stocks setting up. But the Snap crash highlights this big risk.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Neurocrine Biosciences: Q1 Earnings Insights

Neurocrine Biosciences (NASDAQ:NBIX) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Looking Into Neurocrine Biosciences's Return On Capital Employed

Benzinga Pro data, Neurocrine Biosciences (NASDAQ:NBIX) reported Q4 sales of $312.00 million. Earnings fell to a loss of $7.30 million, resulting in a 132.44% decrease from last quarter.

Benzinga

Why Neurocrine Biosciences Are Trading Higher Today?

Neurocrine Biosciences Inc (NASDAQ: NBIX) reported

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations